TAMIEKA ALSTON-GIBSON: Open Payments
NPI 1902273808 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 11 payments from 7 companies in 2025. Trend: 2023 $226 · 2024 $83 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $69 |
| ABBVIE INC. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
Products named: INGREZZA, VRAYLAR, AUSTEDO XR, Veozah, VOQUEZNA, KRYSTEXXA, Korlym.
Industry payments across SC — which companies pay providers there.
